Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2016 2
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Surgical approaches and results of treatment for hereditary paragangliomas.
Iacobone M, Belluzzi A, Torresan F. Iacobone M, et al. Best Pract Res Clin Endocrinol Metab. 2019 Oct;33(5):101298. doi: 10.1016/j.beem.2019.101298. Epub 2019 Jul 27. Best Pract Res Clin Endocrinol Metab. 2019. PMID: 31401056 Review.
This paper was aimed to review the available literature on the epidemiology, diagnosis, clinical features, treatment of PGL in order to discuss the surgical approach and the results of treatment in hereditary PGL....
This paper was aimed to review the available literature on the epidemiology, diagnosis, clinical features, treatment of PGL in order …
Multiple paraganglioma syndrome type 4 due to succinate dehydrogenase B mutation: diagnostic and therapeutic challenges of a skull base paraganglioma masquerading as nasopharyngeal cancer.
Alzahrani AS, Alshaikh O, Faiyaz-Ul-Haque M, Abalkhail H, Al-Dayel F, Hindi HA. Alzahrani AS, et al. Endocr Pract. 2010 May-Jun;16(3):452-8. doi: 10.4158/EP09315.CR. Endocr Pract. 2010. PMID: 20061288
OBJECTIVE: To report a case of hereditary paraganglioma and describe the underlying genetic mutation and response to iodine 131 metaiodobenzylguanidine (MIBG) therapy. ...CONCLUSIONS: This case illustrates the diagnostic and therapeutic challenges of hereditary …
OBJECTIVE: To report a case of hereditary paraganglioma and describe the underlying genetic mutation and response to iodine 13 …
Combined Treatment With 131I-MIBG and Sunitinib Induces Remission in a Patient With Metastatic Paraganglioma Due to Hereditary Paraganglioma-Pheochromocytoma Syndrome From an SDHB Mutation.
Makis W, McCann K, McEwan AJ, Sawyer MB. Makis W, et al. Clin Nucl Med. 2016 Mar;41(3):204-6. doi: 10.1097/RLU.0000000000000973. Clin Nucl Med. 2016. PMID: 26359568
A 22-year-old woman with rapidly progressing metastatic paraganglioma due to hereditary paraganglioma-pheochromocytoma syndrome from an SDHB mutation, who recurred after neoadjuvant chemotherapy, was found to be MIBG avid. ...
A 22-year-old woman with rapidly progressing metastatic paraganglioma due to hereditary paraganglioma-pheochromocytoma syndrom …
Palliation of Extensive Metastatic Bone Disease With 223Ra-Dichloride alpha-Particle Therapy in a Patient With Malignant Hereditary Paraganglioma-Pheochromocytoma Syndrome With SDHB Mutation.
Makis W, McCann K, McEwan AJ, Sawyer MB. Makis W, et al. Clin Nucl Med. 2016 Feb;41(2):144-7. doi: 10.1097/RLU.0000000000000964. Clin Nucl Med. 2016. PMID: 26359562
A 26-year-old woman with a 5-year history of metastatic paraganglioma due to hereditary paraganglioma-pheochromocytoma syndrome with SDHB mutation, who had failed multiple treatment regimens and had transfusion dependent pancytopenia, presented with progressive live …
A 26-year-old woman with a 5-year history of metastatic paraganglioma due to hereditary paraganglioma-pheochromocytoma syndrom …